Breast Cancer Connect
  • Saved
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment - PubMed

Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35269621/

1 Department of Medical Oncology, Campus Bio-Medico University of Rome, 00128 Rome, Italy. 2 Royal Marsden Hospital NHS Trust, London SW3 6JJ, UK. 3 Department of Orthopedic and Trauma Surgery,...


Conclusion/Relevance: Overall, our results revealed the direct effects of CDKi on the tumor bone microenvironment, highlighting differences potentially relevant for clinical practice.

  • Saved
Influence of progesterone receptor on metastasis and prognosis in breast cancer patients with negative HER-2

Influence of progesterone receptor on metastasis and prognosis in breast cancer patients with negative HER-2

Source : https://gs.amegroups.com/article/view/87989/html

The dramatic increase in breast cancer survival in recent years (since the 1970s) has been attributed to the discovery of hormone receptors (HRs), human epidermal factor growth receptor 2 (HER-2)...


Conclusions: ER−/PR subtype had a high proportion of stage IV patients. Meanwhile, such subtype breast cancer had similar clinicopathological characteristics, metastatic models (prefers to visceral metastasis), similar even worse prognosis compared with TNBC.

  • 4yr
    Key Points • Source: Gland Surgery • Conclusions: “ER−/PR+ subtype had a high proportion of stage IV patients. Meanwhile, such subtype breast cancer had similar clinicopathological characteristics, metastatic models (prefers to visceral metastasis), similar Show More
  • 4yr
    I have not had many issues myself
  • Saved
Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination - European Radiology

Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination - European Radiology

Source : https://link.springer.com/article/10.1007/s00330-022-08655-0

Objectives To assess the frequency of ipsilateral axillary adenopathy on breast MRI after COVID-19 vaccination. To investigate the duration, outcomes, and associated variables of vaccine-related adenopathy. Methods In this retrospective...


Conclusions: Vaccine-related adenopathy is a frequent event after COVID-19 vaccination; short-term follow-up is an appropriate clinical approach, except in patients with current ipsilateral breast cancer. Adenopathy may often persist 4–8 weeks after the second dose of the vaccine, thus favoring longer follow-up periods.

  • Saved
Parkinson's disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender | Aging

Parkinson's disease and cancer: a systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender | Aging

Source : https://www.aging-us.com/article/203932/text

Purpose: The relationship between Parkinson's disease (PD) and cancer has been debated. Gender and genetic influences on cancer development in PD is unclear. Methods: Using QUOROM guidelines, we conducted a...


Conclusion: PD patients have reduced risks of colon, rectal, colorectal cancer and lung cancers and increased risks of brain cancer and melanoma. LRRK2-G2019S carriers have increased cancer risks, particularly brain, breast, colon and blood cancers. Female gender was associated with reduced risks. The role of ethnicity, comorbidities, and...

  • Saved
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study

Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study

Source : https://www.frontiersin.org/articles/10.3389/fonc.2021.810023/full

BackgroundCyclin-dependent kinases (CDK) 4 and 6 regulate G1 to S cell cycle progression and are often altered in cancers. Abemaciclib is a selective inhibitor of CDK4 and CDK6 approved for...


Conclusions: Abemaciclib in combination with multiple endocrine therapy options exhibited manageable safety and promising antitumor activity in patients with HR , HER2- MBC.